SNYR Stock Analysis: Buy, Sell, or Hold?
SNYR - Synergy CHC Corp. Common Stock
$0.21
0.00 (0.92%)
▲
5d:
+7.62%
30d:
-18.08%
90d:
-81.51%
BUY
HIGH Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When SNYR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SNYR trading at deep discount. Market pricing in -26.9% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: SNYR trading at deep discount. Market pricing in -26.9% annual earnings decline, creating value opportunity for patient investors.
In-depth Analysis How we analyze
Valuation Analysis: SNYR is currently trading at $0.21, which is considered slightly low relative to its 30-day fair value range of $0.20 to $0.26. From a valuation perspective, the stock is trading at a discount (Forward PE: 1.4) compared to its historical average (3.6). Remarkably, the market is currently pricing in an annual earnings decline of 26.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SNYR is in a strong downtrend. Immediate support is located at $0.18, while resistance sits at $0.38.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.75 (+1695.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SNYR is in a strong downtrend. Immediate support is located at $0.18, while resistance sits at $0.38.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.75 (+1695.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.20 -
$0.26
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1695.1% below Wall St target ($3.75)
Trading Range Analysis
30-Day Trading Range
$0.20 -
$0.26
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.19
Resistance Level
$0.38
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.39
Wall Street Target
$3.75
(+1695.1%)
Revenue Growth (YoY)
-32.8%
Earnings Growth (YoY)
-90.6%
Profit Margin
-57.0%
Valuation Discount vs History
-26.9% cheaper
PE vs Historical
1.4 vs 3.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-26.9%
(market-implied from PE analysis)
1-Year Target
$0.19
(-10%)
2-Year Target
$0.17
(-19%)
3-Year Target
$0.15
(-27%)
3-Yr Target (if PE normalizes)
(PE: 1→4)
$0.39
(+88%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 1.4 to 3.6
Stabilization Target:
$0.54
(+158.5%)
PE Expansion Potential:
+158.5%
Share & Embed Analysis
Last updated: June 24, 2026 5:38 PM ET
Data refreshes hourly during market hours. Next update: 6:38 PM
Data refreshes hourly during market hours. Next update: 6:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNYR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$941 | 61 BUY |
|
COR
Cencora Inc. |
STRONG BUY
14 analysts |
$351 | 63 BUY |
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$245 | 60 BUY |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$88 | 65 BUY |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 53 HOLD |
